Pharmacokinetics and Safety of Levornidazole Disodium Phosphate in Hepatic Impairment

Phase 1, open-label trial of levornidazole in bacterial infection (3 arms), sponsored by Yangtze River Pharmaceutical Group. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time 0 to the Last Measurable Concentration, Area Under the Plasma Concentration-time Curve From Time 0 Extrapolated to Infinity and 1 more. Started Sep 2023; status: completed.